Puma Biotechnology Inc. (PBYI)
NASDAQ · Healthcare
Puma Biotechnology Inc. EBITDA 2017–2025
Puma Biotechnology Inc. annual/quarterly ebitda history and growth rate from 2017 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Puma Biotechnology Inc. ebitda for the quarter ending March 31, 2026 was -1.2 M, a 118.35% decrease year-over-year.
- Puma Biotechnology Inc. ebitda for the twelve months ending March 31, 2026 was 13.4 M, a 45.30% decrease year-over-year.
- Puma Biotechnology Inc. annual ebitda for 2025 was 48.2 M, a 13.53% increase from 2024.
- Puma Biotechnology Inc. annual ebitda for 2024 was 42.5 M, a 3.78% decrease from 2023.
- Puma Biotechnology Inc. annual ebitda for 2023 was 44.2 M, a 31.58% increase from 2022.
- Puma Biotechnology Inc. annual ebitda for 2022 was 33.6 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Puma Biotechnology Inc. EBITDA — FAQ
Puma Biotechnology Inc. (PBYI) ebitda over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PBYI's ebitda history?
The chart and table above show Puma Biotechnology Inc.'s ebitda by year and by quarter, including the growth rate.